Trax buys Shopkick for $200m
The Israeli image recognition for retail goods company has acquired a US company with a platform that provides it with access to consumers.
Can-Fite fights hostile takeover
The Israeli drug development company, which has the worst-performing stock on the Tel Aviv Stock Exchange so far this year, has filed a NIS 40 million lawsuit against Capital Point.
Citi slashes Teva price target
Citi still rates Teva "Buy", but acknowledges that "near-term opioid-related catalysts are unlikely to alleviate investor concerns."